Cross-Sector entity
Every one of those 1 sits in a single category, regulation. Sen. Bill Cassidy is most often covered alongside CDC, which appears in 1 of these 1 story. Each carries 3 original sources on average. We currently track 1 Cross-Sector story that mention Sen. Bill Cassidy, all published on August 6, 2026.
1 verified story tracked
Last mentioned: Aug 6, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, regulation. Sen. Bill Cassidy is most often covered alongside CDC, which appears in 1 of these 1 story. Each carries 3 original sources on average. We currently track 1 Cross-Sector story that mention Sen. Bill Cassidy, all published on August 6, 2026.
Computed from the 1 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Sen. Bill Cassidy. Shared-story counts are live from our verified record — not editorial picks.
Senate confirmation vote
The full Senate voted 51-44 to confirm Dr. Erica Schwartz as CDC director, largely along party lines.
Senator Cassidy’s endorsement
After reviewing the hearing and speaking with colleagues, Sen. Bill Cassidy expressed confidence in Schwartz and voted to advance the nomination.
Confirmation hearing held
Dr. Erica Schwartz testified before the Senate Health, Education, Labor and Pensions Committee, facing tough questions on vaccine independence.
Prior CDC director fired
The last permanent CDC director was dismissed in a dispute over vaccine policy with HHS Secretary Robert F. Kennedy Jr.
The Senate’s 51-44 confirmation of Dr. Erica Schwartz ends an 11-month leadership vacuum at the CDC, just as the agency tackles measles surges, cyclosporiasis, and Ebola. Schwartz inherits an agency hollowed by thousands of departures, raising questions about capacity and scientific independence amid political pressure on vaccine policy.
